Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13317
Country/Region: Uganda
Year: 2014
Main Partner: Joint Clinical Research Center
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,153,357 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

The main goal of the Targeted HIV/AIDS Lab Services (THALAS) program is to increase access to, coverage of, and utilization of quality comprehensive HIV/AIDS and tuberculosis care and treatment services; provide advanced HIV/AIDS care and treatment services for complicated cases referred from other HIV/AIDS care and treatment providers; and provide HIV diagnosis and monitoring services including viral load (VL) testing and DNA PCR for early infant diagnosis (EID). The EID service has been fully transitioned to Central Public Health Laboratories (CPHL). THALAS provides clinical care and adult and pediatric ART services. The project also provides HIV/AIDS routine laboratory monitoring and VL testing for patients. THALAS trains lab staff in manual and automated testing techniques and resident mentors at regional referral and general hospitals enhance delivery of quality services. THALAS supports resident mentors through THALAS preceptor mentors and laboratory quality improvement (QI) teams. THALAS supports capacity building and provides technical assistance for Ministry of Health (MoH) laboratories that enhance quality of lab services. THALAS will continue to scale up HIV/AIDS care and treatment services, implement the revised MoH treatment guidelines, support national laboratory QI practices, and support MoH/CPHL in scaling up lab quality management practices through SLMTA/SLIPTA approaches. The mechanism's current end date is June 2015, but it will be extended until June 2016.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $9,728
Care: TB/HIV (HVTB) $48,662
Laboratory Infrastructure (HLAB) $750,000
Treatment: Adult Treatment (HTXS) $2,283,238
Treatment: Pediatric Treatment (PDTX) $61,729
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 911
C2.1.D By Age: 15+ 2015 10,913
C2.1.D By Age/Sex: <15 Female 2015 485
C2.1.D By Age/Sex: <15 Male 2015 426
C2.1.D By Age/Sex: 15+ Female 2015 7,189
C2.1.D By Age/Sex: 15+ Male 2015 3,724
C2.1.D By Sex: Female 2015 7,685
C2.1.D By Sex: Male 2015 4,139
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 11,824
C2.1.D Sum of Age disaggregates 2015 11,824
C2.1.D Sum of Age/Sex disaggregates 2015 11,824
C2.1.D Sum of Sex disaggregates 2015 11,824
C2.1.D_NGI By Age: <15 2015 911
C2.1.D_NGI By Age: 15+ 2015 10,913
C2.1.D_NGI By Age/Sex: <15 Female 2015 485
C2.1.D_NGI By Age/Sex: <15 Male 2015 426
C2.1.D_NGI By Age/Sex: 15+ Female 2015 7,189
C2.1.D_NGI By Age/Sex: 15+ Male 2015 3,724
C2.1.D_NGI By Sex: Female 2015 7,685
C2.1.D_NGI By Sex: Male 2015 4,139
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 11,824
C2.1.D_NGI Sum of Age disaggregates 2015 11,824
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 11,824
C2.1.D_NGI Sum of Sex disaggregates 2015 11,824
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 11,824
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 10,641
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 532
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 390
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 7,130
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 3,772
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 11,824
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 11,824
CARE_NEW Aggregated Age/sex: <15 Female 2015 7
CARE_NEW Aggregated Age/sex: <15 Male 2015 8
CARE_NEW Aggregated Age/sex: 15+ Female 2015 111
CARE_NEW Aggregated Age/sex: 15+ Male 2015 56
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 182
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 182
FN_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 1
FN_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 1
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 1
FN_SITE Sum of Numerator Support Type disaggregates 2015 1
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 1
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 1
FN_THER Aggregated Age: <18 2015 175
FN_THER Aggregated Age: 18+ 2015 109
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 284
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 3,830
FN_THER Sum of Aggregated Age disaggregates 2015 284
LAB_CAP By clinical laboratories 2015 6
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 6
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 6
LAB_CAP Sum of Site Support Type disaggregates 2015 6
PP_PREV Age/sex: 10-14 Female 2015 230
PP_PREV Age/sex: 10-14 Male 2015 169
PP_PREV Age/sex: 15-19 Female 2015 739
PP_PREV Age/sex: 15-19 Male 2015 402
PP_PREV Age/sex: 20-24 Female 2015 647
PP_PREV Age/sex: 20-24 Male 2015 337
PP_PREV Age/sex: 25-49 Female 2015 1,693
PP_PREV Age/sex: 25-49 Male 2015 889
PP_PREV Age/sex: 50+ Female 2015 66
PP_PREV Age/sex: 50+ Male 2015 36
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 5,208
PP_PREV Sum of Age/Sex disaggregates 2015 5,208
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 6
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 1
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 281
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 1,426
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 9,215
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 11,824
TB_SCREEN Sex: Female 2015 6,938
TB_SCREEN Sex: Male 2015 3,703
TB_SCREEN Sum of Aggregated Age disaggregates 2015 10,641
TB_SCREEN Sum of Sex disaggregates 2015 10,641
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 10,641
TX_CURR Aggregated Age/Sex: <15 Female 2015 462
TX_CURR Aggregated Age/Sex: <15 Male 2015 427
TX_CURR Aggregated Age/Sex: 15+ Female 2015 7,080
TX_CURR Aggregated Age/Sex: 15+ Male 2015 3,581
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 11,550
TX_CURR Sum of Aggregated Age/Sex <15 2015 889
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 10,661
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 11,550
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 462
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 427
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 7,080
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 3,581
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 11,550
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 889
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 10,661
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 11,550
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 10
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 8
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 165
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 64
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 247
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 247
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 161
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 177
Cross Cutting Budget Categories and Known Amounts Total: $750,000
Human Resources for Health $700,000
Gender: Gender Equality $50,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Tuberculosis
Family Planning